Breakthrough ALS Gene Therapy Launches in the Chinese Mainland
Biogen launches Tofersen, a breakthrough gene-targeted drug for ALS in the Chinese mainland, targeting SOD1 mutations and offering new hope.
Biogen
Read More
Stay informed, stay connected—news for amigos everywhere.